New Scores for the Assessment of Mitral Stenosis Using Real-Time Three-Dimensional Echocardiography

被引：19
作者：
Soliman O.I.I. [1 ]
Anwar A.M. [2 ]
Metawei A.K. [2 ]
McGhie J.S. [1 ]
Geleijnse M.L. [1 ]
Ten Cate F.J. [1 ]
机构：
[1] The Thoraxcenter, Department of Cardiology, Erasmus MC, 230 3015 CE Rotterdam
[2] Department of Cardiology, Faculty of Medicine, Al-Azhar University, Cairo
来源：
Current Cardiovascular Imaging Reports | 2011年 / 4卷 / 5期
关键词：
Echocardiography; Mitral valve; Score; Stenosis; Three-dimensional;
D O I：
10.1007/s12410-011-9099-z
中图分类号：
学科分类号：
摘要：
Nonsurgical management of patients with symptomatic mitral valve stenosis has been established as the therapeutic modality of choice for two decades. Catheter-based balloon dilation of the stenotic valvular area has been shown, at least, as effective as surgical interventions. Unfavorable results of catheter-based interventions are largely due to unfavorable morphology of the valve apparatus, particularly leaflets calcification and subvalvular apparatus involvement. A mitral valve score has been proposed in Boston, MA, about two decades ago, based on morphologic assessment of mitral valve apparatus by two-dimensional (2D) echocardiography to predict successful balloon dilation of the mitral valve. Several other scores have been developed in the following years in order to more successfully predict balloon dilatation outcome. However, all those scores were based on 2D echocardiography, which is limited by ability to distinguish calcification and subvalvular involvement. The introduction of new matrix-based ultrasound probe has allowed 3D echocardiography (3DE) to provide more detailed morphologic analysis of mitral valve apparatus including calcification and subvalvular involvement. Recently, a new 3DE scoring system has been proposed by our group, which represents an important leap into refinement of the use of echocardiography guiding mitral valve interventions. © 2011 The Author(s).
引用
收藏
页码：370 / 377
页数：7
相关论文
共 36 条
  • [1] Karthikeyan G., Mayosi B.M., Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in africa?, Circulation, 120, 8, pp. 709-713, (2009)
  • [2] Inoue K., Owaki T., Nakamura T., Et al., Clinical application of transvenous mitral commissurotomy by a new balloon catheter, J Thorac Cardiovasc Surg, 87, 3, pp. 394-402, (1984)
  • [3] Arora R., Kalra G.S., Murty G.S., Et al., Percutaneous transatrial mitral commissurotomy: immediate and intermediate results, J Am Coll Cardiol, 23, 6, pp. 1327-1332, (1994)
  • [4] Ruiz C.E., Zhang H.P., Macaya C., Et al., Comparison of inoue single-balloon versus double-balloon technique for percutaneous mitral valvotomy, Am Hear J, 123, 4 Pt 1, pp. 942-947, (1992)
  • [5] Hung J.S., Lau K.W., Lo P.H., Et al., Complications of inoue balloon mitral commissurotomy: impact of operator experience and evolving technique, Am Hear J, 138, 1 Pt 1, pp. 114-121, (1999)
  • [6] Turi Z.G., Reyes V.P., Raju B.S., Et al., Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis. A prospective, randomized trial, Circulation, 83, 4, pp. 1179-1185, (1991)
  • [7] Ben Farhat M., Ayari M., Maatouk F., Et al., Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial, Circulation, 97, 3, pp. 245-250, (1998)
  • [8] Iung B., Garbarz E., Michaud P., Et al., Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy, Eur Hear J, 21, 20, pp. 1683-1689, (2000)
  • [9] Vahanian A., Michel P.L., Cormier B., Et al., Immediate and mid-term results of percutaneous mitral commissurotomy, Eur Hear J, 12, SUPPL. B, pp. 84-89, (1991)
  • [10] Hung J.S., Chern M.S., Wu J.J., Et al., Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy, Am J Cardiol, 67, 9, pp. 854-862, (1991)
1234